ID   DLP1_MOUSE              Reviewed;         401 AA.
AC   Q33DR3; B2RWA7; B2RWF3; Q3USU6; Q9D3K7;
DT   24-JAN-2006, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 2.
DT   07-APR-2021, entry version 115.
DE   RecName: Full=All trans-polyprenyl-diphosphate synthase PDSS2 {ECO:0000305};
DE   AltName: Full=All-trans-decaprenyl-diphosphate synthase subunit 2 {ECO:0000250|UniProtKB:Q86YH6};
DE            EC=2.5.1.91 {ECO:0000250|UniProtKB:Q86YH6};
DE   AltName: Full=Decaprenyl-diphosphate synthase subunit 2 {ECO:0000312|MGI:MGI:1918615};
DE   AltName: Full=Solanesyl-diphosphate synthase subunit 2;
GN   Name=Pdss2 {ECO:0000312|MGI:MGI:1918615};
GN   Synonyms=Dlp1 {ECO:0000303|PubMed:16262699};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY, AND
RP   SUBUNIT.
RX   PubMed=16262699; DOI=10.1111/j.1742-4658.2005.04956.x;
RA   Saiki R., Nagata A., Kainou T., Matsuda H., Kawamukai M.;
RT   "Characterization of solanesyl and decaprenyl diphosphate synthases in mice
RT   and humans.";
RL   FEBS J. 272:5606-5622(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   STRAIN=C57BL/6J; TISSUE=Corpora quadrigemina, and Head;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=18437205; DOI=10.1371/journal.pgen.1000061;
RA   Peng M., Falk M.J., Haase V.H., King R., Polyak E., Selak M., Yudkoff M.,
RA   Hancock W.W., Meade R., Saiki R., Lunceford A.L., Clarke C.F., Gasser D.L.;
RT   "Primary coenzyme Q deficiency in Pdss2 mutant mice causes isolated renal
RT   disease.";
RL   PLoS Genet. 4:e1000061-e1000061(2008).
RN   [5]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=21871565; DOI=10.1016/j.nbd.2011.08.006;
RA   Lu S., Lu L.Y., Liu M.F., Yuan Q.J., Sham M.H., Guan X.Y., Huang J.D.;
RT   "Cerebellar defects in Pdss2 conditional knockout mice during embryonic
RT   development and in adulthood.";
RL   Neurobiol. Dis. 45:219-233(2012).
CC   -!- FUNCTION: Heterotetrameric enzyme that catalyzes the condensation of
CC       farnesyl diphosphate (FPP), which acts as a primer, and isopentenyl
CC       diphosphate (IPP) to produce prenyl diphosphates of varying chain
CC       lengths and participates in the determination of the side chain of
CC       ubiquinone (PubMed:16262699). Supplies nona and decaprenyl diphosphate,
CC       the precursors for the side chain of the isoprenoid quinones
CC       ubiquinone-9 (Q9) and ubiquinone-10 (Q10) respectively
CC       (PubMed:16262699). The enzyme adds isopentenyl diphosphate molecules
CC       sequentially to farnesyl diphosphate with trans stereochemistry
CC       (PubMed:16262699). May play a role during cerebellar development
CC       (PubMed:21871565). May regulate mitochondrial respiratory chain
CC       function (PubMed:18437205). {ECO:0000269|PubMed:16262699,
CC       ECO:0000269|PubMed:18437205, ECO:0000269|PubMed:21871565}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E,6E)-farnesyl diphosphate + 7 isopentenyl diphosphate =
CC         all-trans-decaprenyl diphosphate + 7 diphosphate;
CC         Xref=Rhea:RHEA:27802, ChEBI:CHEBI:33019, ChEBI:CHEBI:60721,
CC         ChEBI:CHEBI:128769, ChEBI:CHEBI:175763; EC=2.5.1.91;
CC         Evidence={ECO:0000250|UniProtKB:Q86YH6};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:27803;
CC         Evidence={ECO:0000250|UniProtKB:Q86YH6};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E,6E)-farnesyl diphosphate + 6 isopentenyl diphosphate =
CC         all-trans-nonaprenyl diphosphate + 6 diphosphate;
CC         Xref=Rhea:RHEA:55364, ChEBI:CHEBI:33019, ChEBI:CHEBI:58391,
CC         ChEBI:CHEBI:128769, ChEBI:CHEBI:175763;
CC         Evidence={ECO:0000269|PubMed:16262699};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:55365;
CC         Evidence={ECO:0000305|PubMed:16262699};
CC   -!- PATHWAY: Cofactor biosynthesis; ubiquinone biosynthesis.
CC       {ECO:0000269|PubMed:16262699}.
CC   -!- SUBUNIT: Heterotetramer composed of 2 PDSS1/DPS1 and 2 PDSS2/DLP1
CC       subunits. {ECO:0000269|PubMed:16262699}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q33DR3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q33DR3-2; Sequence=VSP_017104, VSP_017105;
CC       Name=3;
CC         IsoId=Q33DR3-3; Sequence=VSP_017102, VSP_017103;
CC   -!- DISRUPTION PHENOTYPE: Homozygous mice for PDSS2 are embryonic lethal
CC       (PubMed:18437205, PubMed:21871565). The oldest PDSS2 embryo identified
CC       is at E9.5, and its morphology resembles normal E6.5 mouse embryo, so
CC       the development of mutant embryo may be blocked at late gastrula stage
CC       (PubMed:18437205, PubMed:21871565). Conditional knockout mice lacking
CC       PDSS2 in cerebellum show severe cerebellum hypoplasia during cerebellum
CC       development, whereas conditional knockout mice lacking PDSS2 in
CC       Purkinje cells at postnatal stages leads to the development of
CC       cerebellar ataxia (PubMed:21871565). Conditional knockout mice lacking
CC       PDSS2 in glomeruli show interstitial nephritis charaterized by greatly
CC       dilated tubules and extensive interstitial infiltration associated with
CC       hypercholesterolemia (PubMed:18437205). Liver-conditional knockout mice
CC       have no overt disease but their livers have undetectable COQ9 levels,
CC       impaired respiratory capacity, and significantly altered intermediary
CC       metabolism (PubMed:18437205). {ECO:0000269|PubMed:18437205,
CC       ECO:0000269|PubMed:21871565}.
CC   -!- SIMILARITY: Belongs to the FPP/GGPP synthase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB210840; BAE48218.1; -; mRNA.
DR   EMBL; AK017329; BAB30693.1; -; mRNA.
DR   EMBL; AK140091; BAE24234.1; -; mRNA.
DR   EMBL; BC147693; AAI47694.1; -; mRNA.
DR   EMBL; BC147694; AAI47695.1; -; mRNA.
DR   EMBL; BC147752; AAI47753.1; -; mRNA.
DR   EMBL; BC147753; AAI47754.1; -; mRNA.
DR   CCDS; CCDS35891.1; -. [Q33DR3-1]
DR   CCDS; CCDS48552.1; -. [Q33DR3-2]
DR   RefSeq; NP_001161761.1; NM_001168289.1. [Q33DR3-2]
DR   RefSeq; NP_082048.2; NM_027772.2. [Q33DR3-1]
DR   SMR; Q33DR3; -.
DR   STRING; 10090.ENSMUSP00000093393; -.
DR   PhosphoSitePlus; Q33DR3; -.
DR   EPD; Q33DR3; -.
DR   MaxQB; Q33DR3; -.
DR   PaxDb; Q33DR3; -.
DR   PeptideAtlas; Q33DR3; -.
DR   PRIDE; Q33DR3; -.
DR   ProteomicsDB; 279435; -. [Q33DR3-1]
DR   ProteomicsDB; 279436; -. [Q33DR3-2]
DR   ProteomicsDB; 279437; -. [Q33DR3-3]
DR   Antibodypedia; 32171; 292 antibodies.
DR   Ensembl; ENSMUST00000095725; ENSMUSP00000093393; ENSMUSG00000038240. [Q33DR3-1]
DR   Ensembl; ENSMUST00000159139; ENSMUSP00000124864; ENSMUSG00000038240. [Q33DR3-2]
DR   GeneID; 71365; -.
DR   KEGG; mmu:71365; -.
DR   UCSC; uc007ezh.2; mouse. [Q33DR3-3]
DR   UCSC; uc007ezi.2; mouse. [Q33DR3-1]
DR   UCSC; uc011xdk.1; mouse. [Q33DR3-2]
DR   CTD; 57107; -.
DR   MGI; MGI:1918615; Pdss2.
DR   eggNOG; KOG0776; Eukaryota.
DR   GeneTree; ENSGT00940000153498; -.
DR   HOGENOM; CLU_014015_3_1_1; -.
DR   InParanoid; Q33DR3; -.
DR   OMA; GRNNMQA; -.
DR   OrthoDB; 858404at2759; -.
DR   PhylomeDB; Q33DR3; -.
DR   TreeFam; TF354277; -.
DR   Reactome; R-MMU-2142789; Ubiquinol biosynthesis.
DR   UniPathway; UPA00232; -.
DR   BioGRID-ORCS; 71365; 18 hits in 53 CRISPR screens.
DR   ChiTaRS; Pdss2; mouse.
DR   PRO; PR:Q33DR3; -.
DR   Proteomes; UP000000589; Chromosome 10.
DR   RNAct; Q33DR3; protein.
DR   Bgee; ENSMUSG00000038240; Expressed in gastrocnemius and 219 other tissues.
DR   Genevisible; Q33DR3; MM.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0005739; C:mitochondrion; HDA:MGI.
DR   GO; GO:1990234; C:transferase complex; IDA:BHF-UCL.
DR   GO; GO:0097269; F:all-trans-decaprenyl-diphosphate synthase activity; ISS:UniProtKB.
DR   GO; GO:0004659; F:prenyltransferase activity; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:HGNC-UCL.
DR   GO; GO:0000010; F:trans-hexaprenyltranstransferase activity; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; IMP:UniProtKB.
DR   GO; GO:0008299; P:isoprenoid biosynthetic process; IDA:HGNC-UCL.
DR   GO; GO:0050878; P:regulation of body fluid levels; IMP:MGI.
DR   GO; GO:0006744; P:ubiquinone biosynthetic process; IDA:HGNC-UCL.
DR   Gene3D; 1.10.600.10; -; 1.
DR   InterPro; IPR008949; Isoprenoid_synthase_dom_sf.
DR   InterPro; IPR000092; Polyprenyl_synt.
DR   Pfam; PF00348; polyprenyl_synt; 1.
DR   SUPFAM; SSF48576; SSF48576; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Isoprene biosynthesis; Mitochondrion;
KW   Reference proteome; Transferase; Ubiquinone biosynthesis.
FT   CHAIN           1..401
FT                   /note="All trans-polyprenyl-diphosphate synthase PDSS2"
FT                   /id="PRO_0000123979"
FT   VAR_SEQ         213..264
FT                   /note="VELLSSALMDLVHGVYQENSASTKENSIPDDIGISTWKEQTFLSHCALLAKS
FT                   -> KAERLTCAHTASGVSCLAAEATDRGVCVLLLSSSMWMLTETDDGDLGSDNMK (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:16141072"
FT                   /id="VSP_017102"
FT   VAR_SEQ         265..401
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:16141072"
FT                   /id="VSP_017103"
FT   VAR_SEQ         350..352
FT                   /note="LRE -> VVS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_017104"
FT   VAR_SEQ         353..401
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_017105"
FT   CONFLICT        132
FT                   /note="A -> S (in Ref. 1; BAE48218)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        204
FT                   /note="L -> I (in Ref. 2; BAB30693)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   401 AA;  43980 MW;  DB7835A83019E5AA CRC64;
     MSLRQLLLRL SGYLGASGPP SRHWWYFRSL DSISSAGSWR GRSSRSPAHW NQVVSEAEKI
     VGYPASFMSL RCLLSDELSN IAMQVRKLVG TGHPLLTTAR ALVHDSRHNL QLRGLVVLLI
     SKAAGPSTRN AACQNYDMVS GVYSCQRSLA EITELIHTAL LVHRGIVNLS ELQSSDGPLK
     DMQFGNKIAI LSGDFLLANA CNGLALLQNT KVVELLSSAL MDLVHGVYQE NSASTKENSI
     PDDIGISTWK EQTFLSHCAL LAKSCQAAME LAKHDAAVQD MAFQYGKHMA MSHKINADLQ
     PFIKDKASDS KTFNLNSAPV VLHQEFLGRD LWIKQIGEAQ EKGSLNYSKL RETIKAGKGV
     TSAIDLCRYH GNKALEALES FPPSEARSAL ENIVFAVTRF S
//
